The expression of phosphorylated neurofilament epitopes in human brains

[1]  L. Otvos,et al.  Identification of the major multiphosphorylation site in mammalian neurofilaments. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Trojanowski,et al.  Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  J. Trojanowski,et al.  Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  W. Freed,et al.  Normal neuronal cell bodies of the nucleus tractus mesencephalici nervi trigemini react with antibodies against phosphorylated epitopes on neurofilaments , 1987, Experimental Neurology.

[5]  M. Mesulam,et al.  Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease , 1987, Annals of neurology.

[6]  H. Cooper,et al.  Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerve , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  D. Selkoe,et al.  Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Frey,et al.  Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles , 1987, Neurology.

[9]  L. Eng,et al.  The cytoskeleton of the human cerebellar cortex: an immunohistochemical study of normal and pathological material , 1987, Brain Research.

[10]  W. Schlaepfer.  Neurofilaments: structure, metabolism and implications in disease. , 1987, Journal of neuropathology and experimental neurology.

[11]  L. Forno,et al.  Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments , 1986, Neuroscience Letters.

[12]  J. Goldman,et al.  Cytoskeletal protein abnormalities in neurodegenerative diseases , 1986, Annals of neurology.

[13]  D L Price,et al.  Phosphorylated Neurofilament Antigens in Neurofibrillary Tangles in Alzheimer's Disease , 1986, Journal of neuropathology and experimental neurology.

[14]  B. Bogerts,et al.  Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage , 1985 .

[15]  D. Price,et al.  Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum , 1985, Brain Research.

[16]  A. Scheibel,et al.  A neurohistological correlate of schizophrenia. , 1984, Biological psychiatry.

[17]  L. Sternberger,et al.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Stevens,et al.  Neuropathology of schizophrenia. , 1982, Archives of general psychiatry.

[19]  J. Julien,et al.  A Comparison of In Vitro‐ and In Vivo Phosphorylated Neurofilament Polypeptides , 1981, Journal of neurochemistry.

[20]  T. Crow,et al.  CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.

[21]  D. Price,et al.  THE RESPONSE OF VENTRAL HORN NEURONS TO AXONAL TRANSECTION , 1972, The Journal of cell biology.

[22]  J. Kleinman,et al.  Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment. , 1980, Archives of general psychiatry.